Medinova Diagno.

Medinova_Diagno.26 Apr 2024

Healthcare

₹

+1.88 (+4.99%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in Medinova Diagno.

Medinova Diagno.

Healthcare

Medinova_Diagno.26 Apr 2024

₹

+1.88 (+4.99%)

OverviewFundamentals

Corporate action

Peer comparison

Income Sheet

Balance sheet

Cash flow

Share holding

About Us

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date
26-Apr-2024	BC	Re-appointment of Mr. Sunil Chandra Kondapally as Managing Director of the Company	25-Sep-2024
19-Apr-2024	BC	MEDINOVA DIAGNOSTIC SERVICES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/04/2024 inter alia to consider and approve Audited Financial Results for	26-Apr-2024
26-Apr-2024	BC	As per the attachment	31-Mar-2024
23-Jan-2024	BC	MEDINOVA DIAGNOSTIC SERVICES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/01/2024 inter alia to consider and approve 1. The un-audited financial r	31-Jan-2024
31-Jan-2024	BC	Appointment of Mr. Nikhil Rajmal Jain, as Chief Financial Officer (CFO) of the Company.	31-Jan-2024

No Rights has been declared by Medinova_Diagno.

Book Closure

Record Date	Split Date	Purpose
25-Sep-2024	-	Re-appointment of Mr. Sunil Chandra Kondapally as Managing Director of the Company
26-Apr-2024	-	MEDINOVA DIAGNOSTIC SERVICES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/04/2024 inter alia to consider and approve Audited Financial Results for
31-Mar-2024	-	As per the attachment
31-Jan-2024	-	MEDINOVA DIAGNOSTIC SERVICES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/01/2024 inter alia to consider and approve 1. The un-audited financial r
31-Jan-2024	-	Appointment of Mr. Nikhil Rajmal Jain, as Chief Financial Officer (CFO) of the Company.

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Medinova Diagnostic Services Ltd ₹39.56(+1.88/4.99%)	39.56	+1.88	39.49	84.95	52.75	-19.37
Shree Pacetronix Ltd ₹243.60(+11.60/5.00%)	243.60	+11.60	87.68	132.02	22.41	7.74
Kovai Medical Center & Hospital Ltd ₹4,193.40(+41.45/1.00%)	4,193.40	+41.45	4,587.58	111.37	29.01	5.87
Chennai Meenakshi Multispeciality Hospital Ltd ₹37.22(-0.23/-0.61%)	37.22	-0.23	27.80	75.15	103.39	155.94
Fortis Malar Hospitals Ltd ₹82.56(+3.93/5.00%)	82.56	+3.93	154.73	65.95	0.00	2.71
Apollo Hospitals Enterprise Ltd ₹6,258.55(-126.75/-1.99%)	6,258.55	-126.75	89,988.35	41.89	90.12	12.34

Income Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Gross Sales	1.92	1.82	2.22	1.82	2.15	1.69
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	1.92	1.82	2.22	1.82	2.15	1.69
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	0.16	0.04	0.03	0.03	0.12	0.03
Total Income	2.07	1.87	2.25	1.85	2.27	1.72
Total Expenditure	1.51	1.53	1.69	1.60	1.55	1.47
PBIDT	0.57	0.34	0.55	0.26	0.72	0.25
Interest	0.14	0.14	0.14	0.14	0.14	0.14
PBDT	0.43	0.19	0.41	0.11	0.58	0.11
Depreciation	0.03	0.03	0.03	0.03	0.03	0.08
Tax	0.10	0.03	0.07	0.01	0.11	0.03
Deferred Tax	0.00	0.01	0.01	0.04	0.01	0.01
Reported Profit After Tax	0.29	0.12	0.30	0.04	0.42	-0.01
Extra-ordinary Items	0.00	0.00	0.00	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	0.29	0.12	0.30	0.04	0.42	-0.01

EPS (Unit Curr.)	0.30	0.12	0.30	0.04	0.42	-0.01
EPS (Adj) (Unit Curr.)	0.30	0.12	0.30	0.04	0.42	-0.01
Calculated EPS (Unit Curr.)	0.30	0.12	0.30	0.04	0.42	-0.01
Calculated EPS (Adj) (Unit Curr.)	0.30	0.12	0.30	0.04	0.42	-0.01
Calculated EPS (Ann.) (Unit Curr.)	1.18	0.47	1.20	0.18	1.68	-0.04
Calculated EPS (Adj) (Ann.) (Unit Curr.)	1.18	0.47	1.20	0.18	1.68	-0.04
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	9.96	9.96	9.96	9.96	9.96	9.96
Reserve & Surplus	0.00	0.00	0.00	0.00	0.00	0.00
Face Value	10.00	10.00	10.00	10.00	10.00	10.00

Public Shareholding (No. Of Shares)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (% in Equity)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	29.69	18.68	24.77	14.29	33.49	14.79
PBDTM(%)	22.40	10.44	18.47	6.04	26.98	6.51
PATM(%)	15.10	6.59	13.51	2.20	19.53	-0.59

Column	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Gross Sales	2.49	2.39	2.87	2.42	2.75	2.22
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	2.49	2.39	2.87	2.42	2.75	2.22
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	0.13	0.03	0.02	0.02	0.16	0.01
Total Income	2.62	2.42	2.88	2.44	2.91	2.24
Total Expenditure	1.75	1.79	1.96	1.89	1.83	1.74
PBIDT	0.88	0.63	0.93	0.55	1.08	0.50
Interest	0.14	0.14	0.14	0.14	0.14	0.14
PBDT	0.74	0.48	0.78	0.41	0.94	0.36
Depreciation	0.03	0.03	0.03	0.03	0.04	0.08
Minority Interest Before NP	0.00	0.00	0.00	0.00	0.00	0.00
Tax	0.10	0.03	0.07	0.01	0.11	0.03
Deferred Tax	0.01	0.02	0.01	0.04	0.02	0.02
Reported Profit After Tax	0.60	0.40	0.66	0.33	0.77	0.23
Minority Interest After NP	0.00	0.00	0.00	0.00	0.00	0.00
Net Profit after Minority Interest	0.60	0.40	0.66	0.33	0.77	0.23

Extra-ordinary Items	0.00	0.00	0.00	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	0.60	0.40	0.66	0.33	0.77	0.23

EPS (Unit Curr.)	0.60	0.40	0.67	0.33	0.78	0.24
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	9.96	9.96	9.96	9.96	9.96	9.96

Public Shareholding (Number)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (%)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	35.34	26.36	32.40	22.73	39.27	22.52
PBDTM(%)	29.72	20.08	27.18	16.94	34.18	16.22
PATM(%)	24.10	16.74	23.00	13.64	28.00	10.36

Balance Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	9.96	9.96	9.96	9.96	9.96	9.96
Reserves Total	-12.79	-13.43	-15.52	-17.63	-17.33	-18.09
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	-2.83	-3.47	-5.56	-7.67	-7.37	-8.13
Secured Loans	0.00	0.00	0.00	0.36	0.36	0.90
Unsecured Loans	5.75	5.75	3.27	3.98	4.12	3.85
Total Debt	5.75	5.75	3.27	4.34	4.48	4.75
Total Liabilities	2.92	2.28	-2.29	-3.33	-2.89	-3.38
APPLICATION OF FUNDS :
Gross Block	4.32	3.94	3.83	4.91	4.91	4.77
Less : Accumulated Depreciation	3.38	3.14	2.93	3.88	3.46	2.93
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	0.94	0.80	0.90	1.03	1.45	1.84
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	0.00	0.00	0.00	0.00	0.00	0.00
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	2.97	2.97	1.27	1.27	1.27	1.29
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	0.11	0.17	0.13	0.06	0.07	0.07
Sundry Debtors	0.67	0.50	0.77	0.31	0.40	0.17
Cash and Bank	0.61	1.31	0.71	0.21	0.05	0.10
Loans and Advances	0.08	0.06	0.04	0.06	0.34	0.78
Total Current Assets	1.47	2.04	1.65	0.64	0.86	1.12
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	2.87	3.89	6.43	6.89	6.51	7.75
Provisions	0.27	0.20	0.15	0.13	0.23	0.14
Total Current Liabilities	3.14	4.09	6.58	7.02	6.74	7.88
Net Current Assets	-1.67	-2.06	-4.93	-6.38	-5.88	-6.76
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	0.57	0.61	0.37	0.41	0.44	0.45
Deferred Tax Liability	0.00	0.00	0.00	0.00	0.00	0.00
Net Deferred Tax	0.57	0.61	0.37	0.41	0.44	0.45
Total Assets	2.82	2.32	-2.39	-3.67	-2.73	-3.18
Contingent Liabilities	0.00	0.00	0.00	0.06	0.06	0.06

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	9.96	9.96	9.96	9.96	9.96	9.96
Reserves Total	-15.09	-16.77	-17.15	-19.13	-18.87	-19.66
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	-5.13	-6.81	-7.19	-9.17	-8.91	-9.70
Minority Interest	0.00	0.00	-0.31	-0.19	-0.22	-0.23
Secured Loans	0.00	0.63	1.20	1.66	2.88	3.91
Unsecured Loans	5.75	5.75	3.27	3.98	3.55	3.35
Total Debt	5.75	6.38	4.47	5.64	6.43	7.26
Policy Holders Fund	0.00	0.00	0.00	0.00	0.00	0.00
Other Liabilities	0.27	0.30	0.65	0.62	0.62	0.63
Total Liabilities	0.89	-0.13	-2.38	-3.10	-2.08	-2.04
APPLICATION OF FUNDS :
Gross Block	9.37	8.98	8.87	11.06	11.06	10.96
Less: Accumulated Depreciation	7.82	7.49	7.00	8.66	7.72	6.48
Less: Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	1.55	1.49	1.87	2.40	3.34	4.48
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	0.00	0.00	0.00	0.00	0.00	0.00
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.00	0.00	0.00	0.00	0.00	0.00
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	0.12	0.18	0.15	0.08	0.10	0.10
Sundry Debtors	0.70	0.52	0.83	0.35	0.47	0.21
Cash and Bank	0.78	1.31	0.71	0.21	0.06	0.11
Loans and Advances	0.09	0.07	0.04	0.06	0.42	0.82
Total Current Assets	1.69	2.07	1.73	0.70	1.04	1.24
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	2.97	4.03	6.61	7.03	6.63	7.98
Provisions	0.63	0.54	0.15	0.13	0.23	0.14
Total Current Liabilities	3.59	4.57	6.76	7.16	6.85	8.11
Net Current Assets	-1.90	-2.50	-5.03	-6.46	-5.81	-6.87
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	0.55	0.59	0.29	0.26	0.21	0.15
Deferred Tax Liability	0.00	0.00	0.00	0.00	0.00	0.00
Net Deferred Tax	0.55	0.59	0.29	0.26	0.21	0.15
Other Assets	0.69	0.29	0.49	0.69	0.19	0.20
Total Assets
Contingent Liabilities	0.00	0.00	0.00	0.06	0.06	0.06

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Cash and Cash Equivalents at Beginning of the year	0.55	0.31	0.07	0.05	0.10
Net Cash from Operating Activities	1.18	1.13	1.51	0.42	0.52
Net Cash Used In Investing Activities	-0.34	-1.84	-0.11	-0.14	-0.13
Net Cash Used In Financing Activities	-0.78	0.94	-1.15	-0.27	-0.43
Net Inc./Dec In Cash And Cash Equivalents	0.06	0.24	0.25	0.01	-0.04
Cash And Cash Equivalents At End Of The Year	0.61	0.55	0.31	0.07	0.05

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

62.14%

FII Shareholding

0.00%

DII Shareholding

0.00%

Public Shareholding

37.86%

**Promoter pledged shareholding 62.14%

About Medinova Diagnostic Services Ltd

Medinova Diagnostic Services Ltd is in the Healthcare sector, having a market capitalization of Rs. 39.49 crores. It has reported a sales of Rs. 1.92 crores and a net profit of Rs. 0.29 crores for the quarter ended December 2018. The company management includes Sura Surendranath Reddy, Sura Surendranath Reddy,Sunil Chandra Kondapally,K V Ravindra Reddy,P Kamalakar Rao,B. Vishnu Priya Reddy (Medinova Diagnostic Services Ltd) among others.

Chairman

Sura Surendranath Reddy

Registered office

HNo 7-1-58/A/FF/8 Unit No 8,Amrutha Business Cplx Ameerpet,Hyderabad,Telangana,500016

FAX :

Background

Incorporation Year1993

Face Value₹10

Market Lot1

How to buy Medinova Diagno. shares on nse?

To buy Medinova Diagno. shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Medinova Diagno. share price today?

The Medinova Diagno. shares price on nse is Rs.39.56 today.

What is the market cap of Medinova Diagno. shares on BSE ?

The company has a market capitalization of Rs.39.49Cr

What is the PE & PB ratio of Medinova Diagno. shares ?

PE is 52.75 and PB is -19.37

What is the 52 Week High and Low of Medinova Diagno. shares?

Medinova Diagno. stock price high: Rs.64.5 Medinova Diagno. stock price low: Rs.20.1